The Centers for Disease Control and Prevention continues to recommend early treatment with antiviral medications for hospitalized patients and high-risk outpatients with flu, including children under 2 years old, the agency said Friday in an advisory. Clinicians also should vaccinate patients for as long as flu viruses are circulating, and promptly start antiviral treatment for severely ill and high-risk patients with suspected flu without waiting for laboratory confirmation, the agency said. Outpatient visits for flu-like illness have been elevated for nine weeks, primarily due to certain influenza B viruses that can cause severe illness in all ages and higher pediatric mortality. Certain influenza A viruses that can cause severe illness also are increasing, CDC said.

Related News Articles

Headline
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global…
Headline
To continue emphasizing the message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns today released new…
Headline
This podcast, in support of AHA’s national strategic alliance with the National Urban League, is bringing attention to health inequities in Black and…
Headline
The Food and Drug Administration Friday authorized the first prescription diagnostic test for both COVID-19 and influenza A and B that allows patients to…
Headline
The Food and Drug Administration yesterday approved using the antiviral treatment Xofluza (baloxavir marboxil) to prevent flu in patients age 12 or older who…
Headline
Adam Myers, M.D., population health chief at Cleveland Clinic, talks with Nancy Foster, AHA vice president for quality and patient safety, about preventing flu…